Neutrophils, airway hyperresponsiveness and COPD: True, true and related?

European Respiratory Journal

Volumn 40, Issue 5, 2012, Pages 1067-1069

  Irvin, Charles G ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; INTERLEUKIN 13; INTERLEUKIN 4; METHACHOLINE; SALMETEROL; STEROID;

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFECT; EDITORIAL; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MOLECULAR PATHOLOGY; MUCUS SECRETION; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT ALLERGY; SYNDROME DELINEATION; TOTAL LUNG CAPACITY;

BRONCHIAL HYPERREACTIVITY; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84868521142     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00129912     Document Type: Editorial

References (21)

1. Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664.
2. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181: 315-323.
3. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
4. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182: 598-604.
5. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacho-line and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309-329.
6. Tepper RS, Wise RS, Covar R, et al. Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol 2012; 129: Suppl. 3, S65-S87.
7. Sumino K, Sugar EA, Irvin CG, et al. Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol 2012; 130: 69-75.
8. Dixon AE, Pratley RE, Forgione PM, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol 2011; 128: 508-515.
9. Cockcroft DW. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138: Suppl. 2, 18S-24S.
10. O'Byrne PM. Conclusion: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138: Suppl. 2, 44S-45S.
11. van den Berge M, Vonk JM, Gosman M, et al. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. Eur Respir J 2012; 40: 1098-1105.
12. Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2009; 151: 517-527.
13. Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157: 4-9.
14. Crimi E, Milanese M, Oddera S, et al. Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol 2001; 91: 1029-1034.
15. Murphy KR, Wilson MC, Irvin CG, et al. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis 1986; 134: 62-68.
16. Irvin CG, Berend N, Henson PM. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg. Am Rev Respir Dis 1986; 134: 777-783.
17. Coyle AJ, Ackerman SJ, Irvin CG. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am Rev Respir Dis 1993; 147: 896-900.
18. Irvin CG, Bates JH. Physiologic dysfunction of the asthmatic lung: what's going on down there, anyway? Proc Am Thorac Soc 2009; 6: 306-311.
19. Wagers S, Lundblad LK, Ekman M, et al. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol 2004; 96: 2019-2027.
20. Riesenfeld EP, Sullivan MJ, Thompson-Figueroa JA, et al. Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir Res 2010; 11: 22.
21. Adner M, Larsson B, Säfholm J, et al. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea. J Pharmacol Exp Ther 2010; 333: 273-280.